Last reviewed · How we verify
NCT06760988
Efficacy of CL22205 to Improve Menstrual Discomfort and Quality of Life
NA trial testing CL22205 in Menstrual Discomfort in 80 participants. Not yet recruiting.
5 October 2025
Quick facts
| Lead sponsor | Eetho Brands, Inc |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | health services research |
| Enrollment | 80 |
| Start date | 24 February 2025 |
| Primary completion | 5 October 2025 |
| Estimated completion | 10 January 2026 |
Drugs / interventions tested
- CL22205
- Placebo
Conditions studied
- Menstrual Discomfort — all drugs for Menstrual Discomfort →
Sponsor
Eetho Brands, Inc
Who can join
Adults 25 to 35, female only, with Menstrual Discomfort. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to evaluate the efficacy of CL22205 to improve menstrual discomfort and quality of life in oligomenorrheic female subjects.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06760988
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of CL22205
Trials testing the same drug.
- NCT06899243 — Efficacy of CL22205 on Bone Mineral Density and Menopausal Symptoms · NA · not yet recruiting
Other recruiting trials for Menstrual Discomfort
Currently open trials in the same condition.
- NCT06492148 — Myofascial Release Technique in Women With Primary Dysmenorrhea · NA · recruiting
Other Eetho Brands, Inc trials
Trials by the same sponsor.
- NCT06899243 — Efficacy of CL22205 on Bone Mineral Density and Menopausal Symptoms · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06760988 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Eetho Brands, Inc
- Last refreshed: 7 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06760988.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing